Comments: US HB8211 | 2023-2024 | 118th Congress

Bill Title: To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.

Spectrum: Partisan Bill (Republican 9-0)

Status: (Introduced) 2024-05-01 - Referred to the House Committee on the Judiciary. [HB8211 Detail]

Text: Not Available

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB8211 at this time.

Social Comments on US HB8211

feedback